OncoCyte (OCX) Stock Chart & Stock Price History $3.10 +0.02 (+0.65%) Closing price 04:00 PM EasternExtended Trading$3.10 +0.00 (+0.16%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock OncoCyte Stock Price Performance 5 Day Performance-9.88%1 Month Performance+3.33%3 Month Performance+49.76%6 Month Performance+3.33%Year-To-Date Performance+30.25%1 Year Performance+21.57% Receive OCX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for OncoCyte and its competitors with MarketBeat's FREE daily newsletter. Email Address OCX Stock Chart for Thursday, May, 1, 2025 OCX Chart by TradingView OncoCyte Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/01/2025$3.08$3.10+0.65%$3.18$2.8743,070 shs$88.66 million04/30/2025$3.12$3.08-1.28%$3.25$3.0861,598 shs$88.09 million04/29/2025$3.22$3.12-3.11%$3.35$3.1019,472 shs$89.23 million04/28/2025$3.44$3.22-6.40%$3.44$3.1924,160 shs$92.09 million04/25/2025$3.39$3.44+1.47%$3.50$3.2688,149 shs$98.38 million04/24/2025$2.95$3.39+14.92%$3.44$3.05169,400 shs$96.95 million04/23/2025$2.92$2.95+1.03%$3.03$2.8228,043 shs$84.37 million04/22/2025$2.88$2.92+1.39%$3.08$2.7882,068 shs$83.51 million04/21/2025$2.84$2.88+1.41%$2.92$2.787,789 shs$82.37 million04/18/2025$2.84$2.84$2.85$2.768,001 shs$81.22 million Get the Latest News and Ratings for OCX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for OncoCyte and its competitors with MarketBeat's FREE daily newsletter. 04/17/2025$2.83$2.84+0.35%$2.85$2.768,001 shs$81.22 million04/16/2025$2.94$2.83-3.74%$2.95$2.8019,903 shs$80.94 million04/15/2025$2.85$2.94+3.16%$3.08$2.9225,484 shs$84.08 million04/14/2025$2.78$2.85+2.52%$2.92$2.7616,505 shs$81.51 million04/11/2025$2.90$2.78-4.14%$2.92$2.7638,218 shs$79.51 million04/10/2025$2.95$2.90-1.69%$2.95$2.8212,058 shs$84.37 million04/09/2025$2.75$2.95+7.27%$3.02$2.6826,069 shs$84.37 million04/09/2025$2.75$2.95+7.27%$3.02$2.6826,069 shs$84.37 million04/08/2025$2.84$2.75-3.17%$3.18$2.7129,206 shs$78.65 million04/08/2025$2.84$2.75-3.17%$3.18$2.7129,206 shs$78.65 million04/07/2025$2.77$2.84+2.53%$2.91$2.6338,208 shs$81.22 million04/04/2025$2.92$2.77-5.14%$2.99$2.7065,248 shs$79.22 million04/03/2025$2.95$2.92-1.02%$3.07$2.8590,983 shs$83.51 million04/02/2025$3.00$2.95-1.67%$3.03$2.8565,068 shs$84.37 million04/01/2025$3.06$3.00-1.96%$3.26$2.8879,273 shs$85.80 million03/31/2025$3.21$3.06-4.67%$3.52$2.9968,567 shs$87.51 million Related Companies Olema Pharmaceuticals Stock Price Chart Benitec Biopharma Stock Price Chart COMPASS Pathways Stock Price Chart Alpha Teknova Stock Price Chart Allogene Therapeutics Stock Price Chart Entrada Therapeutics Stock Price Chart Arcturus Therapeutics Stock Price Chart Taysha Gene Therapies Stock Price Chart Heron Therapeutics Stock Price Chart Atyr PHARMA Stock Price Chart Receive OCX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for OncoCyte and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:OCX) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OncoCyte Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share OncoCyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OCX Stock Free OCX Stock Alerts